Wave Life Sciences (WVE) Other Gross PP&E Adjustments (2016 - 2026)
Wave Life Sciences filings provide 13 years of Other Gross PP&E Adjustments readings, the most recent being -$11.0 million for Q1 2026.
- On a quarterly basis, Other Gross PP&E Adjustments rose 33.7% to -$11.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$11.0 million, a 33.7% increase, with the full-year FY2025 number at $34.7 million, up 15.81% from a year prior.
- Other Gross PP&E Adjustments hit -$11.0 million in Q1 2026 for Wave Life Sciences, down from $34.7 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $34.7 million in Q4 2025 to a low of -$27.8 million in Q3 2022.
- Median Other Gross PP&E Adjustments over the past 5 years was -$16.6 million (2025), compared with a mean of -$8.1 million.
- Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 106.71% in 2023 and later soared 33.7% in 2026.
- Wave Life Sciences' Other Gross PP&E Adjustments stood at $21.0 million in 2022, then increased by 21.99% to $25.6 million in 2023, then grew by 16.74% to $29.9 million in 2024, then grew by 15.81% to $34.7 million in 2025, then plummeted by 131.71% to -$11.0 million in 2026.
- The last three reported values for Other Gross PP&E Adjustments were -$11.0 million (Q1 2026), $34.7 million (Q4 2025), and -$13.9 million (Q3 2025) per Business Quant data.